Bicara Therapeutics Inc.

Q3 2024 13F Holders

Symbol
BCAX
CUSIP
055477103
Type
Equity
Class
COM
Num filings
71
Total reported value, excl. options
$926 M
Manager Report Date Value ($000) Shares Option Type